In a review posted on BMC Medicine, The researchers reviewed the current literature to explore the challenges of malaria vaccination in reaching high-risk children and discussed policy implications.
They identified risks related to the health system that could hinder the effectiveness of the malaria vaccine and proposed solutions to ensure equitable and universal protection against the disease.
Study: Malaria vaccination: barriers to reaching high-risk children. Image credit: Media Lens King/Shutterstock.com
Record
Despite decades of efforts, malaria remains a major health challenge in Africa, prompting the introduction of RTS, S/AS01 and R21/Matrix-M vaccines.
These vaccines offer promising developments, but require further investment in research, development and delivery strategies to maximize their impact.
The researchers in this article examined health system-related risks that could impede universal malaria immunization, focusing on limited government funding for health, vaccine distribution frameworks, and key issues for maximizing impact. The analysis builds on existing research while considering policy implications.
Limited government funding for health
Limited public health funding in most African countries hampers their ability to purchase malaria vaccines in quantities sufficient to cover children at risk. The number needed to vaccinate (NNV) can be calculated based on vaccine efficacy (VE) and the incidence of malaria in unvaccinated children.
Vaccine wastage (VW) rates, which increase with geographic and developmental distance from urban centers, must also be considered.
The financial investment required to purchase vaccines can overwhelm most countries’ health systems, necessitating reliance on development partners.
According to the eligibility criteria set by the Global Alliance for Vaccines and Immunization (Gavi), only 12 African countries have been approved for priority vaccine distribution, covering a small part of the population at risk.
The introduction of the more cost-effective R21 vaccine may improve supply, but transformative changes in health financing are needed to ensure widespread access.
Delivery cost is another barrier, with additional cost per dose required for administration. Achieving universal coverage would require significant financial investment, highlighting the challenge of sustaining vaccination efforts without adequate funding.
Effective planning, financing and coordination, supported by sustainable health financing models, are essential to maximize the public health impact of malaria vaccines.
Strengthening vaccine distribution frameworks
The World Health Organization devised a framework for selecting high-risk areas eligible for Gavi support based on district-level malaria burden and child mortality rates.
However, this approach has limitations, relying on outdated data and overlooking emerging issues such as antimicrobial resistance (AMDR).
AMDR, particularly with antimalarial drugs, affects malaria control strategies and requires consideration in vaccine prioritization. Current methods overlook dynamic epidemiological trends, preventing accurate assessment of needs.
Updating the Prioritization Index with recent and comprehensive data is critical to addressing these deficiencies. Incorporating AMDR markers alongside traditional measurements can improve the accuracy of vaccine allocation.
In addition, the creation of sub-national scoring systems within eligible countries can prioritize regions based on vulnerability and equity.
These frameworks ensure that vaccines reach the most at-risk children in countries, combating the corruption and inequities that often hinder the distribution of resources.
Implementation of these strategies requires robust data systems and stakeholder engagement to effectively monitor and evaluate vaccine distribution.
By prioritizing high-risk areas and addressing systemic barriers, malaria vaccines can maximize their impact in protecting children’s health and contribute to achieving the Sustainable Development Goals (SDGs).
Without such measures, vaccines risk perpetuating inequalities by failing to reach the most vulnerable populations. Therefore, proactive planning and targeted interventions at both national and sub-national levels are necessary.
Addressing key issues
Malaria vaccination efforts in Africa face challenges similar to those that have hampered routine vaccination programs on the continent. Despite ongoing efforts, progress in routine immunization remains below international standards, with many countries falling short of global targets.
Sub-Saharan Africa (SSA) has the highest burden of unvaccinated and undervaccinated children worldwide, highlighting systemic weaknesses in immunization programs.
The limited supply of vaccines, compounded by issues such as vaccine wastage, infrastructure deficiencies, corruption and mismanagement compound these challenges.
Geographical barriers, including the time required to travel to health care facilities, impede access to routine vaccination services, particularly in remote areas.
In addition, lack of investment in sustainable data systems limits evidence-based decision-making and impedes progress in disease control. Without effective use of data, the root causes of public health inadequacies remain unclear, hampering efforts to combat diseases such as malaria.
Compliance with health care financing commitments such as the Abuja Declaration and institutional strengthening are essential steps in overcoming systemic challenges.
Simply integrating malaria vaccines into existing Expanded Program on Immunization (EPI) frameworks without fundamental changes in health systems may not yield the desired results. Transformative change embedded in immunization efforts is needed to maximize their impact on the health of Africa’s children.
conclusion
To effectively combat malaria, lessons learned from past vaccination efforts must inform the development of malaria vaccines. A comprehensive evaluation program is critical prior to launch to identify and address specific challenges.
By urgently addressing these risks and implementing tailored strategies, the potential of malaria vaccines to help control and eliminate the disease can be realized.
